ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii190
Main Authors Carlsson, G.U., Guren, T.K., Haux, J., Pfeiffer, P., Taflin, H., Mavroudis, D., Georgoulias, V., Papadimitriou, C., Kentepozidis, N., Boumpas, D., Skintemo, L., Ganlöv, K.M.E., Gustavsson, B.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy281.115